News
The number of awardees in the government services sector, which includes ministries and stat boards, has been rising. Read ...
Niveditha Mogali is a thought leader in the life science industry and engages in public forums on transforming healthcare ...
GSK PLC closed 21.47% short of its 52-week high of £18.24, which the company reached on May 16th.
As you would probably expect from such a well-known name connected to the healthcare industry, the goals for GSK for this new ...
Going forward, PTS and Appspace are providing ongoing service and support, with a team ensuring the systems perform at peak ...
With the American Association for Cancer Research’s annual conference now underway, oncology researchers can expect ...
Spero Therapeutics, Inc. (Nasdaq: SPRO), a clinical-stage biopharmaceutical company, focused on identifying and developing novel treatments for rare diseases and multi-drug resistant (MDR) bacterial ...
According to the results of the early study, published simultaneously in the New England Journal of Medicine, 92% of patients ...
GSK PLC closed 22.73% below its 52-week high of £18.24, which the company reached on May 16th.
New results from a clinical trial led by Memorial Sloan Kettering Cancer Center (MSK), gastrointestinal oncologists Andrea ...
Penmenvy combines the antigenic components of Bexsero (meningococcal Group B vaccine) and Menveo (meningococcal Groups A, C, Y, and W-135 oligosaccharide diphtheria CRM197 conjugate vaccine).
Abnormal kinase signaling can promote other harmful traits, such as neuroinflammation and neuronal cell death. On the other ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results